Blockade of the PD-1/PD-L1 axis mainly eliminates T cell exhaustion within the tumor microenvironment, while blockade of CTLA-4 promotes the efficient activation and clonal expansion of naive T cells in peripheral lymph nodes. The gene discussed is PDCD1; the disease is neoplasm.